Danielle Kirsh

RT @MassDevice: The future of #CardiacCare was on display at the Heart Rhythm Society’s 2023 annual meeting. #MedicalDevice companies showc…

Today's @MassDevice Fast Five podcast covers executive changes at @IntuitiveSurg, the FDA approval of @AbbottNews' SCS devices for pain management, @SmithNephewPLC's AI-powered surgical robotics tools, @Philips' CPAP device study, and @CookMedical layoffs: https://t.co/bZKqazQFCO

RT @MassDevice: Don't miss today's episode of the MassDevice Fast Five podcast, as we dive into the latest breakthroughs in the #MedicalDev…

🎙️ Tune in to the @MassDevice Fast Five #medtech news podcast to hear about: @BiosenseWebster's QDOT catheter @BrainsWay's dTMS technology @dexcom's G6 CGM system in Japan Onward Medical's SCS breakthrough @Medtronic & @JNJMedTech eyeing Shockwave Medical. https://t.co/rYS2janYhi

“We haven’t had the clinical need to have a robot,” @bostonsci CEO Mike Mahoney says. “I don’t think we’d be good at it.” Mahoney thinks it’s more beneficial for business for BSX to design devices that would work with surgical robots rather than design the robots. #DTB2023 https://t.co/1c07aHiKrS

There’s a jam-packed room for they keynote interview with @bostonsci’s CEO Mike Mahoney. He is discussing how to make the wrong decision work and why Boston Scientific has an exciting future ahead. #DTB2023 https://t.co/u0d5Jpfn4T

“Building into biocompatibility is critical,” says PSN Labs VP Matthew Heidecker. Materials are a core challenge for manufacturing and understanding toxicology and the effect of chemistry on the human body should be considered when designing devices. #DTB2023 https://t.co/1n3UrjcuM1

Have some time between sessions? Check out the expo floor at #DTB2023. Lots of cool innovations to check out from OEMs and contract manufacturers. https://t.co/RDHF8OoNh9

.@MedTechTom is leading a discussion with executives from Philips Ventures, CardiaCare, and Huma to explore delivering real value for medtech with digital health. #DTB2023 https://t.co/hw7vYOQP3F

We have a very packed room for the discussion with @zimmerbiomet’s Nitin Goyal to discuss bringing meaningful innovation to the market. #DTB2023 https://t.co/4Gzz5meTL5

“Crisis doesn’t build character – it reveals character,” says @BDandCo CEO Tom Polen. COVID required everyone to shift initiatives early in the pandemic. Polen said that the company had to scale up diagnostics from making 9M diagnostic tests a year to 12M a month. #DTB2023 https://t.co/ZmUJSuCvO6

We officially have a full room for the keynote interview with @BDandCo’s CEO and President Tom Polen. Come listen in on the conversation about how medtech is playing a role in the digital transformation of healthcare in Room 160ABC. #DTB2023 https://t.co/gvACVkqxjI

When you’re at a small company, you’re always thinking about your next round of capital, says @lifesciencevc. What are the milestones you need to achieve to unlock the next round of investors? You always want someone who has a plan and can think about all the plans. #DTB2023

The room at nearly at capacity for the first @DeviceTalks keynote. There is obviously an interest in engineering entrepreneurship in this economic climate. The panel of investors and career experts are giving lots of great insights about fundraising. #DTB2023 https://t.co/qTvK30yLPz

The medtech industry has had a round of layoffs recently, but there’s hope. “Hiring follows money… the number one accelerator for success is people,” says Holly Scott, VP and senior partner at The Mullings Group.#DTB2023 @DeviceTalks

Engineers are critical to all medtech advancement, but startups rely on their problem solving capabilities more than most. @newmarker is leading the conversation in the first panel of the day about engineering, entrepreneurs and exits. #DTB2023 https://t.co/HJ3i7C3Jz1

.@MedTechTom kicks off @DeviceTalks Boston this morning. Lots of good panels lined up for day 1 and an extensive exhibitor floor. #DTB2023 https://t.co/oEB1Sz4p3v